The complex world of molecular identification just got a financial boost, with life science firm Isospec closing a $400K seed round. The capital will fuel the company's mission to simplify these intricate processes, particularly within the burgeoning fields of glycomics and metabolomics.
Isospec Analytics SA aims to unlock the full potential of these areas, which are critical for discovering new disease biomarkers. Its work also supports the development of safer nutritional and pharmaceutical products, by making advanced molecular analysis more accessible.
